Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

HUMANA INC Director's Dealing 2018

Feb 27, 2018

30145_dirs_2018-02-27_83d3399e-af57-4712-a971-476ca26ee33e.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HUMANA INC (HUM)
CIK: 0000049071
Period of Report: 2018-02-24

Reporting Person: LeClaire Brian P. (Chief Information Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2018-02-24 Humana Common M 3174 Acquired 13062 Direct
2018-02-24 Humana Common F 1040 $269.31 Disposed 12022 Direct
2018-02-26 Humana Common M 4971 $164.645 Acquired 16993 Direct
2018-02-26 Humana Common F 372 $269.31 Disposed 16621 Direct
2018-02-26 Humana Common M 4921 $167.805 Acquired 21542 Direct
2018-02-26 Humana Common S 12719 $274.6785 Disposed 8823 Direct
2018-02-27 Humana Common G 120 Disposed 8703 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2018-02-26 Options $164.645 M 4971 Disposed 2022-02-24 Humana Common (4971) Direct
2018-02-26 Options $167.805 M 4921 Disposed 2023-02-18 Humana Common (4921) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Humana Common 134 Indirect

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Options $217.415 2024-03-08 Humana Common (23247) 23247 Direct
Options $268.47 2025-02-19 Humana Common (6221) 6221 Direct
Restricted Stock Units $ Humana Common (1093) 1093 Direct
Restricted Stock Units $ Humana Common (4159) 4159 Direct
Restricted Stock Units $ Humana Common (1443) 1443 Direct
Phantom Stock Units $ Humana Common (61) 61 Indirect

Footnotes

F1: Stock units held for the benefit of reporting person as of January 31, 2018 under the Humana Retirement & Savings Plan including a routine disposition of shares to fund an administrative fee assessment under a Tax-Conditioned Plan, both exempt under Rule 16b-3(c).

F2: Right to buy pursuant to Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/24/15, vesting in three increments from 02/24/16 to 02/24/18.

F3: Right to buy pursuant to Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/18/16, vesting in three increments from 02/18/17 to 02/18/19.

F4: Right to buy pursuant to Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 03/08/2017. 15,498 options vesting in three annual increments, and 7,749 options fully vest three years from the date of grant.

F5: Right to buy pursuant to Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/19/18, vesting in three increments from 02/19/19 to 02/19/21.

F6: Right to receive one share per restricted stock unit pursuant to the Company's 2011 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F7: Restricted stock units granted to reporting person on 02/18/16, 33% of the award is vesting on 12/15/16, 12/15/17, and 12/15/18.

F8: Restricted stock units granted to reporting person on 03/08/2017, 3,564 shares vesting in three annual increments on 12/15/17, 12/15/18, and 12/15/19. 1,782 shares fully vest three years from the date of grant.

F9: Restricted stock units granted to reporting person on 02/19/18, 33% of the award is vesting on 12/15/18, 12/15/19, and 12/15/20.

F10: Phantom Stock Units held for the benefit of reporting person as of January 31, 2018 based on the value of Humana common stock on a 1-for-1 basis, under the Humana Retirement Equalization Plan. The ending number of units reflects normal fluctation due to changes in stock price.

F11: Includes Performance Stock Units that vested on 2/24/18.

F12: Shares swapped for payment of purchase price on incentive stock option exercise using fair market value on February 23, 2018 pursuant to Humana Inc's 2011 Stock Incentive Plan.

F13: Shares sold at prices ranging from $274.31 to $274.986. Price reported is weighted average sales price.

F14: This transaction represents a gift/charitable donation effective February 27, 2018. This is not a market transaction and no value was received in return for the shares.

F15: The number of Options (14,913) granted on 2/24/15 was correct. Due to scrivener's error, it was changed on 2/24/17 to 14,306. This was a difference of 607 shares that should have remained in Table II for the reporting person.